Why now

The story is timely because India appears to be moving kidney-transplant choice from reputation and referral networks toward published outcome data. Survival, death, graft-failure, and long-term results are not decorative metrics; they change how patients compare hospitals before a life-altering transplant. The news cycle matters because transparency mandates are easiest to cover before the dashboards exist, while the policy pressure and patient-access framing are still fresh.

Why now

The one-year outcome and Lancet publication turn the first bladder transplant from a stunning surgical event into an early durability and complication-learning story.

Why now

A cancer-born cell therapy may have opened a transplant path for patients who were almost impossible to match.